• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Adv Pharm Bull . Studying the Effect of Amino Acid Substitutions in the M2 Ion Channel of the Influenza Virus on the Antiviral Activity of the Amino

tetano

Editor, Senior Moderator
Adv Pharm Bull


. 2021 Sep;11(4):700-711.
doi: 10.34172/apb.2021.079. Epub 2020 Jul 15.
Studying the Effect of Amino Acid Substitutions in the M2 Ion Channel of the Influenza Virus on the Antiviral Activity of the Aminoadamantane Derivative In Vitro and In Silico


Timur Mansurovich Garaev[SUP] 1 [/SUP], Artyom Irorevich Odnovorov[SUP] 2 [/SUP], Alexander Aleksandrovich Lashkov[SUP] 3 [/SUP], Tatiana Vladimirovna Grebennikova[SUP] 1 [/SUP], Marina Pavlovna Finogenova[SUP] 1 [/SUP], Galina Kadymovna Sadykova[SUP] 1 [/SUP], Alexei Gennadievich Prilipov[SUP] 1 [/SUP], Tatiana Anatol'evna Timofeeva[SUP] 1 [/SUP], Sergey Vadimovich Rubinsky[SUP] 3 [/SUP], Svetlana Nikolaevna Norkina[SUP] 1 [/SUP], Marina Mikhailovna Zhuravleva[SUP] 1 [/SUP]



Affiliations

Abstract

Purpose: The aminoadamantane derivative of L-histidyl-1-adamantayl ethylamine hydrochloride (HCl*H-His-Rim) has showed a high inhibition level against influenza A virus strains in vitro. The aim of this work is to search and establish evidence of the direct effect of the drug on influenza A virus proton channel M2. Methods: The compound HCl*H-His-Rim was obtained by classical peptide synthesis methods. Influenza A virus mutants of A/PuertoRico/8/34(H1N1) strain were obtained by reverse genetics methods. The mutant samples of the virus were cultured on chicken embryos with a virus titer in the hemagglutination test. ELISA was carried out on Madin-Darby canine kidney (MDCK) monolayer cells when multiplying the virus 10[SUP]-4[/SUP]-10[SUP]-6[/SUP]. The binding stability of HCl*H-His-Rim was compared to those of M2 (S31N) and M2 (S31N_A30T) channels by molecular dynamic (MD) modeling. The calculation was performed taking into account the interaction with the model lipid bilayer (1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine) in the presence of water molecules in accordance with the three-center model. Results: It was found that HCl*H-His-Rim is a direct action drug against influenza A. The most likely conformation of drug binding to target protein has been shown. It has been found that the A30T mutation reduces the binding energy of the drug, and the results obtained in vitro have confirmed the data calculated in silico. Conclusion: The mechanism of action of HCl*H-His-Rim is directly related to the suppression of the function of the proton channel M2 of influenza A virus.

Keywords: Antiviral; Drug resistance; Influenza virus; M2 proton channel; Molecular docking; Reverse genetics.
 
Back
Top Bottom